Synaptiflora
AI-Powered Microbiome Intelligence Suite for Precision Drug Development
Active
Pre-Funding
Startup
Haifa
Founded 2024-09
Synaptiflora offers an AI-driven microbiome analytics platform aimed at accelerating drug development. The system integrates microbiome composition, metabolomics, and host data via a foundational AI model—SynaptiCore—enabling disease-specific modules for applications like trial optimization and biomarker discovery By translating complex biological data into…
SectorHealth Tech & Life Sciences
StagePre-Funding
Total raised$10K
Employees3
Founded2024-09
HQHaifa
Confidence80
Sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentDigital HealthcareClinical Workflow
Technology
Artificial IntelligenceGenerative AIDeep LearningMachine Learning
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsBiotechnology